Kenneth Bockhorst, the Chairman of $BMI, bought 3,300 shares of the company on 02-10-2026 for an estimated $502,985. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings of this class of stock by approximately 9.0%. Following this trade, they now own 40,013 shares of this class of $BMI stock.
$BMI Insider Trading Activity
$BMI insiders have traded $BMI stock on the open market 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $BMI stock by insiders over the last 6 months:
- KENNETH BOCKHORST (Chairman, President & CEO) purchased 3,300 shares for an estimated $502,985
- ROBERT WROCKLAGE (EVP-N.A. Muncipal Utility) purchased 1,650 shares for an estimated $251,377
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$BMI Hedge Fund Activity
We have seen 234 institutional investors add shares of $BMI stock to their portfolio, and 288 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WESTFIELD CAPITAL MANAGEMENT CO LP removed 612,809 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $109,435,431
- UBS GROUP AG added 335,953 shares (+89.2%) to their portfolio in Q4 2025, for an estimated $58,593,562
- BAMCO INC /NY/ added 254,423 shares (+inf%) to their portfolio in Q3 2025, for an estimated $45,434,859
- PICTET ASSET MANAGEMENT HOLDING SA added 212,448 shares (+39.2%) to their portfolio in Q4 2025, for an estimated $37,053,055
- BANK OF AMERICA CORP /DE/ removed 203,731 shares (-59.6%) from their portfolio in Q3 2025, for an estimated $36,382,281
- AMUNDI added 200,330 shares (+99.5%) to their portfolio in Q3 2025, for an estimated $35,774,931
- BOWEN HANES & CO INC added 198,305 shares (+336.3%) to their portfolio in Q4 2025, for an estimated $34,586,375
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$BMI Analyst Ratings
Wall Street analysts have issued reports on $BMI in the last several months. We have seen 4 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Barclays issued a "Underweight" rating on 01/29/2026
- JP Morgan issued a "Overweight" rating on 01/29/2026
- Jefferies issued a "Buy" rating on 01/29/2026
- RBC Capital issued a "Outperform" rating on 10/22/2025
- Stifel issued a "Buy" rating on 10/22/2025
To track analyst ratings and price targets for $BMI, check out Quiver Quantitative's $BMI forecast page.
$BMI Price Targets
Multiple analysts have issued price targets for $BMI recently. We have seen 6 analysts offer price targets for $BMI in the last 6 months, with a median target of $190.5.
Here are some recent targets:
- Jeffrey Reive from RBC Capital set a target price of $191.0 on 01/29/2026
- Nathan Jones from Stifel set a target price of $166.0 on 01/29/2026
- William Grippin from Barclays set a target price of $136.0 on 01/29/2026
- Michael Fairbanks from JP Morgan set a target price of $190.0 on 01/29/2026
- James Ko from Jefferies set a target price of $200.0 on 01/29/2026
- Robert Mason from Baird set a target price of $205.0 on 10/20/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
